• Laid off Pfizer Inc. (PFE) Staff Return as Contractors More...

• Astellas Pharma Inc. (YPH.BE)' New HQ to Create 150 New Jobs More...

• Ensysce Biosciences Inc. Completes Qualifying Financial Transaction Matching Emerging Technology Funds from the State of Texas More...

• JumpStart Invests $250,000 in GenomOncology More...

• Amylin Pharmaceuticals, Inc. (AMLN) Preps for 2nd Round After Bids Boost Appeal More...

• inVentiv Health (VTIV) Announces Acquisition of Kazaam Interactive More...

• Dr. Reddy's Laboratories Ltd. (RDY), Merck Serono in Pact to Develop Biotech Drug Copies More...

• MorphoSys AG Antibody Reaches Major Milestone in Collaboration With Roche (RHHBY) More...

• ChinaBio(R) LLC Release: Four Companies Join Forces to Form Pan-Asia Pacific Clinical CRO More...

• Australian National University to Grant BioDiem Ltd. (BDM.AX) Exclusive License for Novel Technology to Target Infectious Diseases More...

• Affymetrix (Santa Clara, California) (AFFX) Announces Research Collaboration with Massachusetts General Hospital to Validate and Develop New Oncology Biomarker Tests More...

• Avrio Biopharmaceuticals Appoints Laura Jones, Ph.D., J.D., M.S., M.B.A., as Vice President of Quality and Regulatory Affairs More...

• Gilead Sciences, Inc. (GILD) Appoints Two New Members to Health Policy Advisory Board More...

• Enzo Biochem (ENZ) Schedules Teleconference to Discuss 2012 Third Quarter Results on June 12, 2012 at 8:30 AM E.T. More...

• Nordion International Release: Reports Second Quarter 2012 Financial Results More...

• FDA Rejects Merck & Co., Inc. (MRK)/Ariad Pharmaceuticals, Inc. (ARIA) Sarcoma Pill More...

• FDA Seeks Data on Delivery Method for Amylin Pharmaceuticals, Inc. (AMLN) Drug More...

• Perrigo Co. (PRGO) Receives FDA Approval for Calcium Acetate Capsules More...
• Mylan Inc. (MYL) Canada Receives Health Canada Approval for Generic Version of Tracleer® More...

• Roche (RHHBY)'s Actemra Beats Abbott Laboratories (ABT) Drug in RA Trial More...

• 62% of Childhood Arthritis Patients Were Symptom-free With Novartis AG (NVS)'s ACZ885 More...

• Celgene International Sarl (CELG) Advances ABRAXANE® (nab-paclitaxel) Development in Difficult-to-Treat Cancers More...

• Janssen Research & Development, LLC Releaes: New Phase 3 Data Show SIMPONI® Intravenous Formulation Significantly Improved Rheumatoid Arthritis Signs And Symptoms In Patients With Active Disease More...

• Janssen Research & Development Release: New Phase 3 Data Show STELAR® Significantly Reduced Signs And Symptoms Of Active Psoriatic Arthritis More...

• Exercise "No Help for Depression", Study Funded by National Institutes of Health (NIH) More...

• Low-Dose Aspirin Use Ups Bleeding Risk, Consorzio Mario Negri Sud Study More...

• Type 2 Diabetes Linked to Increased Blood Cancer Risk, Miriam HospitalStudy More...

• Anxious Girls' Brains Work Harder, Michigan State University Study More...

• Why Some Touches Make Our Skin Crawl, California Institute of Technology Study More...

• pSivida Corp (PSDV) Announces Issuance of US Patent for Inserter to Be Used in Planned Phase III Uveitis Trials More...

• Depomed, Inc. (DEPO) Announces Issuance of Formulation Patent Covering Gralise® (gabapentin) More...